No Prescription |
 |
 | ||
|
DIABUSE Antabuse |
|
| ||
No Prescription » Prescription Drugs 5 » DIABUSE Antabuse Disulfiram is used to treat chronic alcoholism. It causes unpleasant effects when even small amounts of alcohol are consumed. These effects include flushing of the face headache nausea vomiting chest pain weakness blurred vision mental confusion sweating choking breathing difficulty and anxiety. These effects begin about 10 minutes after alcohol enters the body and last for 1 hour or more. Disulfiram is not a cure for alcoholism but discourages drinking.Disulfiram comes in tablets to take by mouth. It should be taken once a day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take disulfiram exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.If you cannot swallow the tablets crush them and mix the medication with water coffee tea milk soft drink or fruit juice. Buy DIABUSE Antabuse and other Prescription Drugs 5 products online at Medstore. 4547
About DIABUSE Antabuse: Product Type: Prescription Drugs 5 DIABUSE ( Antabuse Generic Disulfiram ) DIABUSE (Antabuse Generic Disulfiram) Antabuse Generic Disulfiram 500 mg 4 x 100 Tablets Antabuse Generic Disulfiram DIABUSE
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
